ProfileGDS4459 / ENSG00000125991
TitleIntraportal tacrolimus flushing effect on liver allograft
OrganismHomo sapiens


flushed with tacrolimus flushed with albumin control GSM623464 GSM623465 GSM623466 GSM623467 GSM623468 GSM623469 GSM623470 GSM623471 GSM623472 GSM623473 GSM623474 GSM623475 GSM623476 GSM623477 GSM623478 GSM623479 GSM623480 90% 86% 99% 92% 94% 91% 98% 97% 98% 98% 85% 98% 97% 84% 98% 83% 85% sort by protocol Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM623464group A, liver allograft wedge biopsie tacrolimus treatment 17.1590
GSM623465group A, liver allograft wedge biopsie tacrolimus treatment 26.5986
GSM623466group A, liver allograft wedge biopsie tacrolimus treatment 39.8499
GSM623467group A, liver allograft wedge biopsie tacrolimus treatment 47.3692
GSM623468group A, liver allograft wedge biopsie tacrolimus treatment 58.0494
GSM623469group A, liver allograft wedge biopsie tacrolimus treatment 67.491
GSM623470group A, liver allograft wedge biopsie tacrolimus treatment 79.3598
GSM623471group A, liver allograft wedge biopsie tacrolimus treatment 89.0497
GSM623472group A, liver allograft wedge biopsie tacrolimus treatment 99.5298
GSM623473group A, liver allograft wedge biopsie tacrolimus treatment 109.2798
GSM623474group B, liver allograft wedge biopsie placebo treatment 16.6885
GSM623475group B, liver allograft wedge biopsie placebo treatment 29.298
GSM623476group B, liver allograft wedge biopsie placebo treatment 3997
GSM623477group B, liver allograft wedge biopsie placebo treatment 46.2684
GSM623478group B, liver allograft wedge biopsie placebo treatment 59.3198
GSM623479group B, liver allograft wedge biopsie placebo treatment 66.2483
GSM623480group B, liver allograft wedge biopsie placebo treatment 76.5285